The RITMO (Registro Italiano sul trattamento del Tronco coMune non protettO) observational study will appraise the prevalence, management strategy, and prognosis of unprotected left main coronary artery disease in Italy.
The RITMO (Registro Italiano sul trattamento del Tronco coMune non protettO) observational study will be a prospective, multicenter, observational study aiming to appraise the prevalence, management strategy, and prognosis (up to 5 years) of unprotected left main coronary artery disease in Italy. A total of 45 Italian secondary and tertiary care centers will participate, and enroll patients during a period of 12 to 18 months. Patients will be included provided that they complete a written informed consent form and significant unprotected left main coronary artery disease is established at diagnostic coronary angiography. The primary end-point will be the 12-month rate of major adverse cerebro-cardiovascular events (ie death, myocardial infarction, stroke, or coronary revascularization).
Study Type
OBSERVATIONAL
Enrollment
1,200
Division of Cardiology, University of Turin
Turin, To, Italy
RECRUITINGmajor adverse cerebro-cardiovascular events (ie death, myocardial infarction, stroke, or coronary revascularization)
Time frame: 12 months
major adverse cerebro-cardiovascular events
Time frame: 60 months
Canadian Cardiac Society functional class
Time frame: 60 months
quality of life (EuroQoL)
Time frame: 60 months
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.